Journal of IiMER Volume 10 Issue 1 Research The Yale Journal of Biology and Medicine 88:383-388. 3) Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. (2015) Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): National Academies Press (US). Available from: http://www.ncbi.nlm.nih.gov/books/NB K274235/ doi: 10.17226/19012 4) Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker K, White PD (2015). Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. Lancet Psychiatry 2: 1067–1074. 5) White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, Baber HL, Burgess M, Clark LV, Cox DL, Bavinton J, Angus BJ, Murphy G, Murphy M, O'Dowd H, Wilks D, McCrone P, Chalder T, Sharpe M (2011) Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. The Lancet 377: 823 – 836. 6) Friedberg F, Bateman L, Bested AC, Davenport T, Friedman KJ, Gurwitt A, Leonard LA, Lapp CW, Stevens SR, Underhill RA, Vallings R (2014) ME/CFS: A Primer for Clinical Practitioners. Chicago, International Association for Chronic Fatigue Encephalomyelitis. 7) Vallings R (2012) Chronic Fatigue Syndrome M.E. Symptoms, Diagnosis & Management Calico Publishing Ltd, New Zealand, edited by Linda Cassells, pp1-350. Syndrome/Myalgic 9) Dementia Economic Report 2012. Alzheimers New Zealand. http://www.alzheimers.org.nz/newsand-events/nz-information/dementiaeconomic-report-2012 10) Lombardi VC, Ruscetti FW, Das Gupta J, Pfost JD, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, PetrowSadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585–589. 11) Fluge Ø1, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H, Mella O (2011) Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A doubleblind and placebo-controlled study. PLoS One. 6(10):e26358. doi:10.1371/journal.pone.0026358. 12) Brenu EW1, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM (2012) Longitudinal investigation of natural killer cells and cytokines in chronic fatigue USA: encephalomyelitis. Translational Medicine 9:88. doi: 10.1186/1479-5876-10-88. 13) Brenu EW, Ashton KJ, Batovska J, Staines DR, Marshall-Gradisnik SM (2014) High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis. PLoS One 9: e102783 Invest in ME (Charity Nr. 1114035) www.investinme.org Page 54 of 77 June 2016 8) Vallings R (2015) Managing ME CFS A Guide for Young People. Calico Publishing Ltd, New Zealand edited by Linda Cassells, pp1-145. syndrome/myalgic Journal

55 Publizr Home

You need flash player to view this online publication